These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 20696039)

  • 1. Frequent associations between CTL and T-Helper epitopes in HIV-1 genomes and implications for multi-epitope vaccine designs.
    Paul S; Piontkivska H
    BMC Microbiol; 2010 Aug; 10():212. PubMed ID: 20696039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of novel targets for multi-epitope vaccines: screening of HIV-1 genomes using association rule mining.
    Paul S; Piontkivska H
    Retrovirology; 2009 Jul; 6():62. PubMed ID: 19580659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired processing and presentation of cytotoxic-T-lymphocyte (CTL) epitopes are major escape mechanisms from CTL immune pressure in human immunodeficiency virus type 1 infection.
    Yokomaku Y; Miura H; Tomiyama H; Kawana-Tachikawa A; Takiguchi M; Kojima A; Nagai Y; Iwamoto A; Matsuda Z; Ariyoshi K
    J Virol; 2004 Feb; 78(3):1324-32. PubMed ID: 14722287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation.
    Yusim K; Kesmir C; Gaschen B; Addo MM; Altfeld M; Brunak S; Chigaev A; Detours V; Korber BT
    J Virol; 2002 Sep; 76(17):8757-68. PubMed ID: 12163596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective Suppression of HIV-1 Replication by Cytotoxic T Lymphocytes Specific for Pol Epitopes in Conserved Mosaic Vaccine Immunogens.
    Zou C; Murakoshi H; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Hanke T; Takiguchi M
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antiviral efficacy of HIV-specific CD8⁺ T-cells to a conserved epitope is heavily dependent on the infecting HIV-1 isolate.
    Ranasinghe SR; Kramer HB; Wright C; Kessler BM; di Gleria K; Zhang Y; Gillespie GM; Blais ME; Culshaw A; Pichulik T; Simmons A; Rowland-Jones SL; McMichael AJ; Dong T
    PLoS Pathog; 2011 May; 7(5):e1001341. PubMed ID: 21589893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
    Murakoshi H; Akahoshi T; Koyanagi M; Chikata T; Naruto T; Maruyama R; Tamura Y; Ishizuka N; Gatanaga H; Oka S; Takiguchi M
    J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long-term follow-up of an HIV type 1-infected patient reveals a coincidence of Nef-directed cytotoxic T lymphocyte effectors and high incidence of epitope-deleted variants.
    Singh MK; Janvier G; Calvez V; Coulaud P; Rivière Y
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1265-71. PubMed ID: 11559426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOBEC3G Regulation of the Evolutionary Race Between Adaptive Immunity and Viral Immune Escape Is Deeply Imprinted in the HIV Genome.
    Borzooee F; Joris KD; Grant MD; Larijani M
    Front Immunol; 2018; 9():3032. PubMed ID: 30687306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping HIV-1 vaccine induced T-cell responses: bias towards less-conserved regions and potential impact on vaccine efficacy in the Step study.
    Li F; Finnefrock AC; Dubey SA; Korber BT; Szinger J; Cole S; McElrath MJ; Shiver JW; Casimiro DR; Corey L; Self SG
    PLoS One; 2011; 6(6):e20479. PubMed ID: 21695251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.
    Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD
    J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic cells focus CTL responses toward highly conserved and topologically important HIV-1 epitopes.
    Garcia-Bates TM; Palma ML; Anderko RR; Hsu DC; Ananworanich J; Korber BT; Gaiha GD; Phanuphak N; Thomas R; Tovanabutra S; Walker BD; Mellors JW; Piazza PA; Kroon E; Riddler SA; Michael NL; Rinaldo CR; Mailliard RB;
    EBioMedicine; 2021 Jan; 63():103175. PubMed ID: 33450518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fitness-Balanced Escape Determines Resolution of Dynamic Founder Virus Escape Processes in HIV-1 Infection.
    Sunshine JE; Larsen BB; Maust B; Casey E; Deng W; Chen L; Westfall DH; Kim M; Zhao H; Ghorai S; Lanxon-Cookson E; Rolland M; Collier AC; Maenza J; Mullins JI; Frahm N
    J Virol; 2015 Oct; 89(20):10303-18. PubMed ID: 26223634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching and emergence of CTL epitopes in HIV-1 infection.
    Han C; Kawana-Tachikawa A; Shimizu A; Zhu D; Nakamura H; Adachi E; Kikuchi T; Koga M; Koibuchi T; Gao GF; Sato Y; Yamagata A; Martin E; Fukai S; Brumme ZL; Iwamoto A
    Retrovirology; 2014 May; 11():38. PubMed ID: 24886641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation sequencing analyses of the emergence and maintenance of mutations in CTL epitopes in HIV controllers with differential viremia control.
    Caetano DG; Côrtes FH; Bello G; Teixeira SLM; Hoagland B; Grinsztejn B; Veloso VG; Guimarães ML; Morgado MG
    Retrovirology; 2018 Sep; 15(1):62. PubMed ID: 30201008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CTL epitope distribution patterns in the Gag and Nef proteins of HIV-1 from subtype A infected subjects in Kenya: use of multiple peptide sets increases the detectable breadth of the CTL response.
    Currier JR; Visawapoka U; Tovanabutra S; Mason CJ; Birx DL; McCutchan FE; Cox JH
    BMC Immunol; 2006 Apr; 7():8. PubMed ID: 16620386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals.
    Setiawan LC; Gijsbers EF; van Nuenen AC; Kootstra NA
    J Gen Virol; 2015 Aug; 96(8):2372-2380. PubMed ID: 25872744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA supertypes contribute in HIV type 1 cytotoxic T lymphocyte epitope clustering in Nef and Gag proteins.
    Chakraborty S; Rahman T; Chakravorty R; Kuchta A; Rabby A; Sahiuzzaman M
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):270-8. PubMed ID: 23061377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conservation of cytotoxic T lymphocyte (CTL) epitopes as a host strategy to constrain parasite adaptation: evidence from the nef gene of human immunodeficiency virus 1 (HIV-1).
    da Silva J; Hughes AL
    Mol Biol Evol; 1998 Oct; 15(10):1259-68. PubMed ID: 9787432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.